Eton Pharmaceuticals Inc (ETON) Stock Analysis

Eton Pharmaceuticals Inc (ETON) is a publicly traded company in the HEALTHCARE sector. It trades at $27.40, carries a market capitalization of $785.61M. This page summarizes the public market data, fundamentals, and frequently asked questions for ETON, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Eton Pharmaceuticals Inc currently has a Neutral sentiment score of -0.05.

About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Deer Park, Illinois, focused on developing and commercializing innovative therapies for patients with rare diseases. With a strong pipeline of proprietary products, Eton is committed to addressing significant unmet medical needs, thereby improving patient outcomes in niche markets. The company's emphasis on research and development, complemented by strategic partnerships, positions it as a pivotal entity in the pharmace...

GNG Research Analysis

GNG Research scores Eton Pharmaceuticals Inc (ETON) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ETON.

Frequently Asked Questions

Does ETON pay dividends?

Eton Pharmaceuticals Inc (ETON) does not currently pay a regular dividend.

What is ETON's market cap?

Eton Pharmaceuticals Inc (ETON) has a market capitalization of $785.61M with a current stock price of $27.40.